Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

NCT00812305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Hepatic Impairment

Interventions

DRUG: SKY0402 300mg in healthy patients
DRUG: SKY0402 300mg in hepatically impaired patients

Sponsor

Pacira Pharmaceuticals, Inc